Pathology and classification of SCLC MG Raso, N Bota-Rabassedas, II Wistuba Cancers 13 (4), 820, 2021 | 116 | 2021 |
Cancer becomes wasteful: emerging roles of exosomes† in cell-fate determination F Wendler, N Bota-Rabassedas, X Franch-Marro Journal of extracellular vesicles 2 (1), 22390, 2013 | 76 | 2013 |
Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth C Barceló, N Paco, M Morell, B Alvarez-Moya, N Bota-Rabassedas, ... Cancer research 74 (4), 1190-1199, 2014 | 73 | 2014 |
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma X Tan, P Banerjee, EA Pham, FUN Rutaganira, K Basu, ... Science Translational Medicine 12 (527), 2020 | 52 | 2020 |
Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding HF Guo, CL Tsai, M Terajima, X Tan, P Banerjee, MD Miller, X Liu, J Yu, ... Nature communications 9 (1), 512, 2018 | 48 | 2018 |
Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer M Yamauchi, DL Gibbons, C Zong, JJ Fradette, N Bota-Rabassedas, ... Matrix biology 91, 8-18, 2020 | 46 | 2020 |
Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis MJ Schliekelman, CJ Creighton, BN Baird, Y Chen, P Banerjee, ... Scientific reports 7 (1), 6478, 2017 | 46 | 2017 |
The ISG15-specific protease USP18 regulates stability of PTEN LM Mustachio, M Kawakami, Y Lu, J Rodriguez-Canales, B Mino, ... Oncotarget 8 (1), 3, 2017 | 44 | 2017 |
A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma X Tan, L Shi, P Banerjee, X Liu, HF Guo, J Yu, N Bota-Rabassedas, ... The Journal of Clinical Investigation 131 (1), 2021 | 31 | 2021 |
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells P Banerjee, GY Xiao, X Tan, VJ Zheng, L Shi, MNB Rabassedas, H Guo, ... Nature communications 12 (1), 6354, 2021 | 26 | 2021 |
Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity N Bota-Rabassedas, P Banerjee, Y Niu, W Cao, J Luo, Y Xi, X Tan, ... Cell reports 35 (3), 2021 | 21 | 2021 |
International association for the study of lung cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy S Dacic, W Travis, M Redman, A Saqi, WA Cooper, A Borczuk, JH Chung, ... Journal of Thoracic Oncology 18 (10), 1290-1302, 2023 | 19 | 2023 |
A collagen glucosyltransferase drives lung adenocarcinoma progression in mice HF Guo, N Bota-Rabassedas, M Terajima, B Leticia Rodriguez, ... Communications biology 4 (1), 482, 2021 | 18 | 2021 |
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21. 3–amplified lung adenocarcinoma cells L Shi, X Tan, X Liu, J Yu, N Bota-Rabassedas, Y Niu, J Luo, Y Xi, C Zong, ... Proceedings of the National Academy of Sciences 118 (25), e2023537118, 2021 | 15 | 2021 |
Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy, and chemoimmunotherapy in resectable NSCLC P Rocha, J Zhang, R Laza-Briviesca, A Cruz-Bermúdez, ... Clinical Cancer Research 28 (11), 2461-2473, 2022 | 12 | 2022 |
FGF coordinates air sac development by activation of the EGF ligand Vein through the transcription factor PntP2 J Cruz, N Bota-Rabassedas, X Franch-Marro Scientific reports 5 (1), 17806, 2015 | 12 | 2015 |
Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment S Dacic, X Cao, N Bota-Rabassedas, B Sanchez-Espiridion, ... Journal of Thoracic Oncology 19 (2), 273-284, 2024 | 7 | 2024 |
Pathology and classification of SCLC. Cancers. 2021; 13 (4): 820 MG Raso, N Bota-Rabassedas, II Wistuba DOI: https://doi. org/10.3390/cancers13040820, 0 | 5 | |
Use of osteoblast-derived matrix to assess the influence of collagen modifications on cancer cells N Bota-Rabassedas, HF Guo, P Banerjee, Y Chen, M Terajima, ... Matrix biology plus 8, 100047, 2020 | 3 | 2020 |